151 related articles for article (PubMed ID: 30141426)
1. Positive somatostatin receptor imaging does not predict somatostatin analogue efficacy in tumor-induced osteomalacia.
Łebek-Szatańska A; Papierska L; Marcinowska-Suchowierska E; Nowak KM; Zgliczyński W; Misiorowski W
Pol Arch Intern Med; 2018 Sep; 128(9):554-555. PubMed ID: 30141426
[No Abstract] [Full Text] [Related]
2. Unusual case of phosphaturic mesenchymal tumor.
Papierska L; Ćwikła JB; Misiorowski W; Rabijewski M; Sikora K; Wanyura H
Pol Arch Med Wewn; 2013; 123(5):255-6. PubMed ID: 23722193
[No Abstract] [Full Text] [Related]
3. Curative surgical treatment after inefficient long-acting somatostatin analogues therapy of a tumor-induced osteomalacia.
Mékinian A; Ladsous M; Balavoine AS; Carnaille B; Aubert S; Soudan B; Wémeau JL
Presse Med; 2011 Mar; 40(3):309-13. PubMed ID: 21131163
[No Abstract] [Full Text] [Related]
4. Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia.
Nguyen BD; Wang EA
Clin Nucl Med; 1999 Feb; 24(2):130-1. PubMed ID: 9988077
[No Abstract] [Full Text] [Related]
5. Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment.
Janson ET; Oberg K
Cancer Chemother Biol Response Modif; 2003; 21():535-46. PubMed ID: 15338762
[No Abstract] [Full Text] [Related]
6. Somatostatin receptor scintigraphy of a patient with a giant invasive prolactinoma.
Meyer P; Bohnen NI; Barkan AL; Shapiro B
Nuklearmedizin; 1999; 38(2):66-7. PubMed ID: 10100234
[TBL] [Abstract][Full Text] [Related]
7. [Somatostatin analogue (octreotide)].
Sano K; Makuuchi M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():674-7. PubMed ID: 11762035
[No Abstract] [Full Text] [Related]
8. Tumor-induced osteomalacia caused by a phosphaturic mesenchymal tumor of the femur.
Liu SZ; Zhou X; Song A; Huo Z; Wang YP; Liu Y
Chin Med J (Engl); 2019 Oct; 132(19):2380-2381. PubMed ID: 31567385
[No Abstract] [Full Text] [Related]
9. Somatostatin Analogues in Neuroendocrine Tumors.
Kulke MH
J Natl Compr Canc Netw; 2016 Mar; 14(3):241-2. PubMed ID: 26957610
[No Abstract] [Full Text] [Related]
10. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
Nilsson O; Kölby L; Wängberg B; Wigander A; Billig H; William-Olsson L; Fjälling M; Forssell-Aronsson E; Ahlman H
Br J Cancer; 1998 Feb; 77(4):632-7. PubMed ID: 9484822
[TBL] [Abstract][Full Text] [Related]
11. The tumour vanishes.
Todd JF; Meeran K
Clin Endocrinol (Oxf); 2000 Dec; 53(6):663-4. PubMed ID: 11155085
[No Abstract] [Full Text] [Related]
12. Somatostatin agonists for treatment of acromegaly.
Ben-Shlomo A; Melmed S
Mol Cell Endocrinol; 2008 May; 286(1-2):192-8. PubMed ID: 18191325
[TBL] [Abstract][Full Text] [Related]
13. [Somatostatin receptor scintigraphy in a patient with metastatic hemangiopericytoma].
Müller V; Klutmann S; Clausen M
Nuklearmedizin; 2003 Jun; 42(3):N13-4. PubMed ID: 12848152
[No Abstract] [Full Text] [Related]
14. Evaluation of somatostatin analogues for the detection and treatment of gastrinoma in a dog.
Altschul M; Simpson KW; Dykes NL; Mauldin EA; Reubi JC; Cummings JF
J Small Anim Pract; 1997 Jul; 38(7):286-91. PubMed ID: 9239629
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study.
Kouroumalis E; Skordilis P; Thermos K; Vasilaki A; Moschandrea J; Manousos ON
Gut; 1998 Mar; 42(3):442-7. PubMed ID: 9577356
[TBL] [Abstract][Full Text] [Related]
16. Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours.
Angeletti S; Corleto VD; Schillaci O; Marignani M; Annibale B; Moretti A; Silecchia G; Scopinaro F; Basso N; Bordi C; Delle Fave G
Gut; 1998 Jun; 42(6):792-4. PubMed ID: 9691916
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy.
Rhee Y; Lee JD; Shin KH; Lee HC; Huh KB; Lim SK
Clin Endocrinol (Oxf); 2001 Apr; 54(4):551-4. PubMed ID: 11318793
[TBL] [Abstract][Full Text] [Related]
18. [Somatostatin receptors--new diagnostic and therapeutic possibilities].
Pawlikowski M
Endokrynol Pol; 2005; 56(1):4-5. PubMed ID: 16335666
[No Abstract] [Full Text] [Related]
19. Somatostatin receptor scintigraphy in the management of cerebral malignant ectomesenchymoma: a case report.
Papós M; Pekrun A; Herms JW; Behr TM; Meller J; Rustenbeck HH; Kretzschmar HA; Becker W
Pediatr Radiol; 2001 Mar; 31(3):169-72. PubMed ID: 11297080
[TBL] [Abstract][Full Text] [Related]
20. Octreotide.
Lamberts SW; van der Lely AJ; de Herder WW; Hofland LJ
N Engl J Med; 1996 Jan; 334(4):246-54. PubMed ID: 8532003
[No Abstract] [Full Text] [Related]
[Next] [New Search]
